Article

Lim, Aaron Guanliang and Aas, Christer Frode and Çağlar, Ege Su and Vold, Jørn Henrik and Fadnes, Lars Thore and Vickerman, Peter and Johansson, Kjell Arne (2023) Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: an economic evaluation of the INTRO-HCV trial. Addiction , 118 , (12) , pp. 2424-2439.

Vold, Jørn Henrik and Skurtveit, Svetlana and Aas, Christer and Chalabianloo, Fatemeh and Kloster, Pia Synnøve and Johansson, Kjell Arne and Fadnes, Lars Thore (2020) Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017. BMC Health Services Research , 20 , (352) , p. 352.

Druckrey-Fiskaaen, Karl Trygve and Madebo, Tesfaye and Daltveit, Jan Tore and Vold, Jørn Henrik and Furulund, Einar and Chalabianloo, Fatemeh and Gilje Lid, Torgeir and Fadnes, Lars Thore (2025) Integrated nicotine replacement and behavioral support to reduce smoking in opioid agonist therapy: a randomized clinical trial. JAMA Psychiatry , Early online .

Druckrey-Fiskaaen, Karl Trygve and Furulund, Einar and Daltveit, Jan Tore and Vold, Jørn Henrik and Lid, Torgeir Gilje and Madebo, Tesfaye and Fadnes, Lars Thore (2022) Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). Trials , 23 .

Vold, Jørn Henrik and Aas, Christer and Skurtveit, Svetlana and Odsbu, Ingvild and Chalabianloo, Fatemeh and Reutfors, Johan and Halmøy, Anne and Johansson, Kjell Arne and Fadnes, Lars Thore (2020) Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ Open , 10 , (8) , e036860.